{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:42:37Z","timestamp":1781926957204,"version":"3.54.5"},"reference-count":40,"publisher":"Impact Journals, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2024,8,14]]},"DOI":"10.18632\/oncotarget.28638","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T18:20:59Z","timestamp":1723659659000},"page":"575-587","source":"Crossref","is-referenced-by-count":4,"title":["A nanobody against the V-ATPase c subunit inhibits metastasis of 4T1-12B breast tumor cells to lung in mice"],"prefix":"10.18632","volume":"15","author":[{"given":"Zhen","family":"Li","sequence":"first","affiliation":[{"name":"Program in Pharmacology and Drug Development, Graduate School of Biomedical Sciences, Tufts University, Boston, MA 02111, USA"},{"name":"Department of Cancer Immunology and Virology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA"},{"name":"These authors contributed equally to this work"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"Alshagawi","sequence":"additional","affiliation":[{"name":"Program in Pharmacology and Drug Development, Graduate School of Biomedical Sciences, Tufts University, Boston, MA 02111, USA"},{"name":"Department of Pharmacology, University of Minnesota School of Medicine, MN 55455, USA"},{"name":"These authors contributed equally to this work"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Oot","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY 13210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam K.","family":"Alamoudi","sequence":"additional","affiliation":[{"name":"Department of Developmental, Molecular, and Chemical Biology, Tufts University School of Medicine, Boston, MA 02111, USA"},{"name":"Department of Pharmacology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Su","sequence":"additional","affiliation":[{"name":"Program in Pharmacology and Drug Development, Graduate School of Biomedical Sciences, Tufts University, Boston, MA 02111, USA"},{"name":"Korro Bio, Cambridge, MA 02139, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Li","sequence":"additional","affiliation":[{"name":"Program in Pharmacology and Drug Development, Graduate School of Biomedical Sciences, Tufts University, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Collins","sequence":"additional","affiliation":[{"name":"Program in Cellular, Molecular and Developmental Biology, Graduate School of Biomedical Sciences, Tufts University, Boston, MA 02111, USA"},{"name":"Foghorn Therapeutics, Cambridge, MA 02139, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Wilkens","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY 13210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Forgac","sequence":"additional","affiliation":[{"name":"Department of Developmental, Molecular, and Chemical Biology, Tufts University School of Medicine, Boston, MA 02111, USA"},{"name":"Program in Pharmacology and Drug Development, Graduate School of Biomedical Sciences, Tufts University, Boston, MA 02111, USA"},{"name":"Program in Cellular, Molecular and Developmental Biology, Graduate School of Biomedical Sciences, Tufts University, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"7","author":"Jemal","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1186\/s12885-019-6311-z","article-title":"The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer","volume":"1","author":"Niu","year":"2019","journal-title":"BMC Cancer"},{"key":"3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrc.2016.25","article-title":"Targeting metastasis","volume":"1","author":"Steeg","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor metastasis: molecular insights and evolving paradigms","volume":"14","author":"Weinberg","year":"2011","journal-title":"Cell"},{"key":"5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature17038","article-title":"Metastatic colonization by circulating tumour cells","volume":"52","author":"Obenauf","year":"2016","journal-title":"Nature"},{"key":"6","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1158\/0008-5472.CAN-19-0458","article-title":"Defining the Hallmarks of Metastasis","volume":"7","author":"Hurst","year":"2019","journal-title":"Cancer Res"},{"key":"7","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrc3110","article-title":"Dysregulated pH: a perfect storm for cancer progression","volume":"1","author":"Barber","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.tibs.2015.08.005","article-title":"Recent Insights into the Structure, Regulation, and Function of the V-ATPases","volume":"4","author":"Forgac","year":"2015","journal-title":"Trends Biochem Sci"},{"key":"9","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1152\/physrev.00035.2015","article-title":"The Function of V-ATPases in Cancer","volume":"9","author":"Forgac","year":"2016","journal-title":"Physiol Rev"},{"key":"10","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nrm2272","article-title":"Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology","volume":"8","author":"Forgac","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-3-319-25304-6_3","article-title":"Proton Transport and pH Control in Fungi","volume":"89","author":"Kane","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"12","doi-asserted-by":"publisher","first-page":"C1443","DOI":"10.1152\/ajpcell.00407.2003","article-title":"Vacuolar H+-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity","volume":"28","author":"Mart\u00ednez-Zaguil\u00e1n","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"13","doi-asserted-by":"publisher","first-page":"16400","DOI":"10.1074\/jbc.M901201200","article-title":"Function of a subunit isoforms of the V-ATPase in pH homeostasis andinvasion of MDA-MB231 human breast cancer cells","volume":"28","author":"Forgac","year":"2009","journal-title":"J Biol Chem"},{"key":"14","doi-asserted-by":"publisher","first-page":"32731","DOI":"10.1074\/jbc.M113.503771","article-title":"The function of vacuolar ATPase (V-ATPase) a subunit isoforms in invasiveness of MCF10a and MCF10CA1a human breast cancer cells","volume":"28","author":"Forgac","year":"2013","journal-title":"J Biol Chem"},{"key":"15","doi-asserted-by":"publisher","first-page":"46142","DOI":"10.18632\/oncotarget.10063","article-title":"The a3 isoform of subunit a of the vacuolar ATPase localizes to the plasma membrane of invasive breast tumor cells and is overexpressed in human breast cancer","volume":"7","author":"Forgac","year":"2016","journal-title":"Oncotarget"},{"key":"16","doi-asserted-by":"publisher","first-page":"11248","DOI":"10.1074\/jbc.RA119.007713","article-title":"Isoform-specific gene disruptions reveal a role for the V-ATPase subunit a4 isoform in the invasiveness of 4T1-12B breast cancer cells","volume":"29","author":"Forgac","year":"2019","journal-title":"J Biol Chem"},{"key":"17","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1002\/ijc.27811","article-title":"Inhibitors of vacuolar ATPase proton pumps inhibit human prostate cancer cell invasion and prostate-specific antigen expression and secretion","volume":"13","author":"Parra","year":"2013","journal-title":"Int J Cancer"},{"key":"18","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1074\/jbc.M114.611210","article-title":"Activity of plasma membrane V-ATPases is critical for the invasion of MDA-MB231 breast cancer cells","volume":"29","author":"Forgac","year":"2015","journal-title":"J Biol Chem"},{"key":"19","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/jcb.10477","article-title":"Effects of Bafilomycin A1: an inhibitor of vacuolar H (+)-ATPases on endocytosis and apoptosis in RAW cells and RAW cell-derived osteoclasts","volume":"8","author":"Zheng","year":"2003","journal-title":"J Cell Biochem"},{"key":"20","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1126\/science.aaz2924","article-title":"Structure of V-ATPase from the mammalian brain","volume":"36","author":"Rubinstein","year":"2020","journal-title":"Science"},{"key":"21","doi-asserted-by":"publisher","first-page":"3921","DOI":"10.1038\/s41467-020-17762-9","article-title":"Cryo-EM structures of intact V-ATPase from bovine brain","volume":"1","author":"Li","year":"2020","journal-title":"Nat Commun"},{"key":"22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nri.2017.19","article-title":"Mechanisms of central tolerance for B cells","volume":"1","author":"Nemazee","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"23","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1158\/1535-7163.MCT-17-0129","article-title":"Inhibition of the V-ATPase by Archazolid A: A New Strategy to Inhibit EMT","volume":"1","author":"Pachmayr","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"24","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1158\/1541-7786.MCR-10-0449","article-title":"The a3 isoform vacuolar type H-ATPase promotes distant metastasis in the mouse B16 melanoma cells","volume":"9","author":"Yoneda","year":"2011","journal-title":"Mol Cancer Res"},{"key":"25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12943-018-0811-3","article-title":"The curious case of vacuolar ATPase: regulation of signaling pathways","volume":"1","author":"Beaman","year":"2018","journal-title":"Mol Cancer"},{"key":"26","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.molonc.2016.01.003","article-title":"Selective inhibition of tumor cell associated Vacuolar-ATPase \u2018a2\u2019 isoform overcomes cisplatin resistance in ovarian cancer cells","volume":"1","author":"Beaman","year":"2016","journal-title":"Mol Oncol"},{"key":"27","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1002\/1878-0261.12782","article-title":"In vivo anti-V-ATPase antibody treatment delays ovarian tumor growth by increasing antitumor immune responses","volume":"1","author":"Beaman","year":"2020","journal-title":"Mol Oncol"},{"key":"28","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1074\/jbc.M112.412007","article-title":"Mode of cell death induction by pharmacological vacuolar H+-ATPase (V-ATPase) inhibition","volume":"28","author":"Vollmar","year":"2013","journal-title":"J Biol Chem"},{"key":"29","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1242\/jeb.028803","article-title":"Regulation of the V-ATPase in kidney epithelial cells: dual role in acid-base homeostasis and vesicle trafficking","volume":"21","author":"Marshansky","year":"2009","journal-title":"J Exp Biol"},{"key":"30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/79208","article-title":"Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing","volume":"2","author":"Karet","year":"2000","journal-title":"Nat Genet"},{"key":"31","doi-asserted-by":"publisher","first-page":"C392","DOI":"10.1152\/ajpcell.00442.2020","article-title":"The H-ATPase (V-ATPase): from proton pump to signaling complex in health and disease","volume":"32","author":"Brown","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"32","doi-asserted-by":"publisher","first-page":"C1454","DOI":"10.1152\/ajpcell.00319.2001","article-title":"V-type H+-ATPase in the human eccrine sweat duct: immunolocalization and functional demonstration","volume":"28","author":"Laprade","year":"2002","journal-title":"Am J Physiol Cell Physiol"},{"key":"33","doi-asserted-by":"publisher","first-page":"gaac005","DOI":"10.1093\/molehr\/gaac005","article-title":"Acrosomal alkalinization occurs during human sperm capacitation","volume":"2","author":"Darszon","year":"2022","journal-title":"Mol Hum Reprod"},{"key":"34","doi-asserted-by":"publisher","first-page":"8760","DOI":"10.1074\/jbc.275.12.8760","article-title":"Three subunit a isoforms of mouse vacuolar H(+)-ATPase","volume":"27","author":"Futai","year":"2000","journal-title":"Preferential expression of the a3 isoform during osteoclast differentiation. J Biol Chem"},{"key":"35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/77131","article-title":"Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis","volume":"2","author":"Villa","year":"2000","journal-title":"Nat Genet"},{"key":"36","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/bcr2781","article-title":"Breast cancer metastasis to the bone: mechanisms of bone loss","volume":"1","author":"Mastro","year":"2010","journal-title":"Breast Cancer Res"},{"key":"37","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/1471-2407-8-228","article-title":"Imagable 4T1 model for the study of late stage breast cancer","volume":"8","author":"Sahagian","year":"2008","journal-title":"BMC Cancer"},{"key":"38","doi-asserted-by":"publisher","first-page":"39856","DOI":"10.1074\/jbc.M406767200","article-title":"Topological characterization of the c, c\u2019, and c\u201d subunits of the vacuolar ATPase from the yeast Saccharomyces cerevisiae","volume":"27","author":"Stevens","year":"2004","journal-title":"J Biol Chem"},{"key":"39","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1080\/19420862.2016.1212149","article-title":"Phage display-derived human antibodies in clinical development and therapy","volume":"8","author":"Hust","year":"2016","journal-title":"MAbs"},{"key":"40","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/BF00300234","article-title":"Determination of subcutaneous tumor size in athymic (nude) mice","volume":"2","author":"Reynolds","year":"1989","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28638","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T11:41:32Z","timestamp":1723722092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,8,14]]}},"alternative-id":["28638"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.28638","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,14]]}}}